{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:50:48Z","timestamp":1791057048885,"version":"4.1.0"},"reference-count":32,"publisher":"Cambridge University Press (CUP)","issue":"9","license":[{"start":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T00:00:00Z","timestamp":1420156800000},"content-version":"unspecified","delay-in-days":2680,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:sec id=\"S0195941700047263_abs1\"><jats:title>Background.<\/jats:title><jats:p>Whole-body washing with antiseptic solution has been widely used as part of eradication treatment for colonization with methicillin-resistant<jats:italic>Staphylococcus aureus<\/jats:italic>(MRSA), but evidence for the effectiveness of this measure is limited.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700047263_abs2\"><jats:title>Objective.<\/jats:title><jats:p>To study the efficacy of whole-body washing with chlorhexidine for the control of MRSA.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700047263_abs3\"><jats:title>Design.<\/jats:title><jats:p>Randomized, placebo-controlled, double-blinded clinical trial.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700047263_abs4\"><jats:title>Setting.<\/jats:title><jats:p>University Hospital of Heidelberg and surrounding nursing homes.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700047263_abs5\"><jats:title>Patients.<\/jats:title><jats:p>MRSA carriers who were not treated concurrently with antibiotics effective against MRSA were eligible for the study.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700047263_abs6\"><jats:title>Intervention.<\/jats:title><jats:p>Five days of whole-body washing with either 4% chlorhexidine solution (treatment group) or with a placebo solution. All patients received mupirocin nasal ointment and chlorhexidine mouth rinse. The outcome was evaluated 3, 4, 5, 9, and 30 days after treatment with swab samples taken from several body sites.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700047263_abs7\"><jats:title>Results.<\/jats:title><jats:p>Of 114 patients enrolled in the study (56 in the treatment group and 58 in the placebo group), 11 did not finish treatment (8 from the treatment group and 3 from the placebo group [<jats:italic>P<\/jats:italic>= .02]). At baseline, the groups did not differ with regard to age, sex, underlying condition, site of MRSA colonization, or history of MRSA eradication treatment. Eleven patients were MRSA-free 30 days after treatment (4 from the treatment group and 7 from the placebo group [<jats:italic>P<\/jats:italic>= .47]). Only groin-area colonization was significantly better eradicated by the use of chlorhexidine. The best predictor for total eradication was a low number of body sites positive for MRSA. Adverse effects were significantly more frequent in the treatment group than in the placebo group (any symptom, 71% vs 33%) but were reversible in most cases.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700047263_abs8\"><jats:title>Conclusion.<\/jats:title><jats:p>Whole-body washing can reduce skin colonization, but it appears necessary to extend eradication measures to the gastrointestinal tract, wounds, and\/or other colonized body sites if complete eradication is the goal.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700047263_abs9\"><jats:title>Trial Registration.<\/jats:title><jats:p>ClinicalTrials.gov identifier: NCT00266448.<\/jats:p><\/jats:sec>","DOI":"10.1086\/519929","type":"journal-article","created":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T14:20:01Z","timestamp":1186064401000},"page":"1036-1043","source":"Crossref","is-referenced-by-count":101,"title":["Value of Whole-Body Washing With Chlorhexidine for the Eradication of Methicillin-Resistant<i>Staphylococcus aureus:<\/i>A Randomized, Placebo-Controlled, Double-Blind Clinical Trial"],"prefix":"10.1017","volume":"28","author":[{"given":"C.","family":"Wendt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"W\u00fcrttemberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Oberdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bock-Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"von Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2015,1,2]]},"reference":[{"key":"S0195941700047263_ref031","doi-asserted-by":"publisher","DOI":"10.1007\/BF02026133"},{"key":"S0195941700047263_ref024","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2002.00404.x"},{"key":"S0195941700047263_ref012","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/JCM.33.9.2233-2239.1995","article-title":"Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing","volume":"33","author":"Tenover","year":"1995","journal-title":"J Clin Microbiol"},{"key":"S0195941700047263_ref028","doi-asserted-by":"publisher","DOI":"10.1017\/S0195941700065802"},{"key":"S0195941700047263_ref027","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.7.3163-3166.2003"},{"key":"S0195941700047263_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/0195-6701(92)90074-V"},{"key":"S0195941700047263_ref022","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0934-8859(99)80041-8","article-title":"Eradication of MRSA from carriers by means of whole-body washing with an antiseptic in combination with mupirocin nasal ointment","volume":"202","author":"Sloot","year":"1999","journal-title":"Zentrabl Hyg Umweltmed"},{"key":"S0195941700047263_ref021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2004.01.008"},{"key":"S0195941700047263_ref025","doi-asserted-by":"publisher","DOI":"10.2307\/30142361"},{"key":"S0195941700047263_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6701(03)00140-3"},{"key":"S0195941700047263_ref007","doi-asserted-by":"publisher","DOI":"10.1007\/s001030050227"},{"key":"S0195941700047263_ref016","doi-asserted-by":"publisher","DOI":"10.1086\/379325"},{"key":"S0195941700047263_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6701(97)90228-0"},{"key":"S0195941700047263_ref032","unstructured":"Dutch Working Party on Infection Prevention. MRSA in nursing homes, 2005. Available at: http:\/\/www.wip.nl\/UK\/. Accessed February 9, 2007."},{"key":"S0195941700047263_ref023","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1128\/AAC.43.6.1412","article-title":"Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus","volume":"43","author":"Harbarth","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"S0195941700047263_ref019","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-3-9"},{"key":"S0195941700047263_ref026","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00404-6"},{"key":"S0195941700047263_ref010","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","year":"2003"},{"key":"S0195941700047263_ref030","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800054224"},{"key":"S0195941700047263_ref015","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/3.5.473"},{"key":"S0195941700047263_ref001","volume-title":"Cochrane Database Syst Rev","author":"Loeb","year":"2003"},{"key":"S0195941700047263_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/0196-6553(88)90053-3"},{"key":"S0195941700047263_ref008","doi-asserted-by":"publisher","DOI":"10.1086\/502098"},{"key":"S0195941700047263_ref003","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/22.3.377"},{"key":"S0195941700047263_ref011","volume-title":"Clinical Microbiological Procedures Handbook","author":"Pfaller","year":"1992"},{"key":"S0195941700047263_ref029","doi-asserted-by":"publisher","DOI":"10.1017\/S0195941700066935"},{"key":"S0195941700047263_ref009","first-page":"149","volume-title":"European Pharmacopoeia","year":"2002"},{"key":"S0195941700047263_ref004","doi-asserted-by":"publisher","DOI":"10.2307\/30144277"},{"key":"S0195941700047263_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(90)92434-M"},{"key":"S0195941700047263_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)90235-5"},{"key":"S0195941700047263_ref013","doi-asserted-by":"publisher","DOI":"10.1086\/510392"},{"key":"S0195941700047263_ref018","first-page":"274","volume-title":"Disinfection, Sterilization and Preservation","author":"Denton","year":"1991"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0195941700047263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T15:22:36Z","timestamp":1587828156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0195941700047263\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0195941700047263"],"URL":"https:\/\/doi.org\/10.1086\/519929","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}